Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong · Delayed Price · Currency is HKD 44.02
-0.86 (-1.92%)
At close: Apr 17, 2026
Sunshine Lake Pharma Market Cap
Sunshine Lake Pharma has a market cap or net worth of 25.36 billion as of April 17, 2026. Its market cap has increased by 187.56% in one year.
Market Cap
25.36B
Enterprise Value
28.88B
Revenue
5.36B
Ranking
n/a
PE Ratio
83.63
Stock Price
44.02
Market Cap Chart
Since December 29, 2015, Sunshine Lake Pharma's market cap has increased from 6.55B to 25.36B, an increase of 286.95%. That is a compound annual growth rate of 14.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 25.36B | -3.50% |
| Dec 31, 2025 | 26.27B | 212.32% |
| Dec 31, 2024 | 8.41B | 0.74% |
| Dec 29, 2023 | 8.35B | 46.00% |
| Dec 30, 2022 | 5.72B | 6.56% |
| Dec 31, 2021 | 5.37B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 39.96B |
| Simcere Pharmaceutical Group | 36.08B |
| China Medical System Holdings | 34.90B |
| Grand Pharmaceutical Group | 23.85B |
| The United Laboratories International Holdings | 20.34B |
| Xuanzhu Biopharmaceutical | 18.66B |
| Fujian Haixi Pharmaceuticals | 15.06B |
| CanSino Biologics | 13.90B |